Загрузка...
Response adaptive randomization procedures in seamless phase II/III clinical trials
It is desirable to work efficiently and cost effectively to evaluate new therapies in a time-sensitive and ethical manner without compromising the integrity and validity of the development process. The seamless phase II/III clinical trial has been proposed to meet this need, and its efficient, ethic...
Сохранить в:
| Опубликовано в: : | J Biopharm Stat |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6957739/ https://ncbi.nlm.nih.gov/pubmed/31454295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2019.1657439 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|